Combined Hypofractionated Radiation and Hormone Therapy for the Treatment of Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2007.09.004 ◽

2008 ◽

Vol 71 (1) ◽

pp. 58-63 ◽

Author(s):

Michael Yassa ◽

Bernard Fortin ◽

Marie-Andrée Fortin ◽

Carole Lambert ◽

Thu Van Nguyen ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation

Download Full-text

7033 Five-year results of disease control and quality of life analysis of a combined hypofractionated radiation and hormone therapy regimen for intermediate-risk prostate cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71411-9 ◽

2009 ◽

Vol 7 (2) ◽

pp. 416

Author(s):

A. Roux ◽

M. Yassa ◽

C. Lambert ◽

B. Fortin ◽

M. Audet-Lapointe ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Disease Control ◽

Hormone Therapy ◽

Intermediate Risk ◽

Therapy Regimen ◽

Risk Prostate Cancer ◽

Life Analysis ◽

Hypofractionated Radiation

Download Full-text

Five-year Results of Disease Control and Quality of Life Analysis of a Combined Hypofractionated Radiation and Hormone Therapy Regimen for Intermediate-risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.737 ◽

2009 ◽

Vol 75 (3) ◽

pp. S321 ◽

Author(s):

A. Roux ◽

M. Yassa ◽

C. Lambert ◽

B. Fortin ◽

M. Audet-Lapointe ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Disease Control ◽

Hormone Therapy ◽

Intermediate Risk ◽

Therapy Regimen ◽

Risk Prostate Cancer ◽

Life Analysis ◽

Hypofractionated Radiation

Download Full-text

Dose Escalation Impacts Biochemical Outcomes of Inadequate PSA Nadir During Neoadjuvant Hormone Therapy Before Brachytherapy for Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.06.926 ◽

2013 ◽

Vol 87 (2) ◽

pp. S352-S353

Author(s):

A. Yorozu ◽

S. Saito ◽

K. Toya ◽

K. Yoshida ◽

A. Takahashi ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Dose Escalation ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Download Full-text

Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy

Radiation Oncology ◽

10.1186/1748-717x-8-137 ◽

2013 ◽

Vol 8 (1) ◽

pp. 137 ◽

Author(s):

Maurizio Valeriani ◽

Stefano Bracci ◽

Mattia Osti ◽

Teresa Falco ◽

Linda Agolli ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Intermediate Risk ◽

Image Guided Radiotherapy ◽

Image Guided ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation

Download Full-text

Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial

BJU International ◽

10.1111/bju.14925 ◽

2019 ◽

Vol 125 (2) ◽

pp. 215-225

Author(s):

Victor A. Macias ◽

Inmaculada Barrera-Mellado

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Phase Ii Trial ◽

Intermediate Risk ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation Therapy ◽

Hypofractionated Radiation

Download Full-text

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1120 ◽

2017 ◽

Vol 99 (2) ◽

pp. E216 ◽

Author(s):

P. Bonome ◽

M.F. Osti ◽

M. Giuliani ◽

V. De Sanctis ◽

D. Caivano ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Cancer Patients ◽

Intermediate Risk ◽

Image Guided ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation Therapy ◽

Hypofractionated Radiation

Download Full-text

A Biopsy Based Genomic Classifier Predicts Biochemical Failure and Metastasis after Definitive Radiation without Hormone Therapy in a Prospective Cohort of Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.254 ◽

2018 ◽

Vol 102 (3) ◽

pp. S99

Author(s):

M.L.K. Chua ◽

R.G. Bristow ◽

J. Murgic ◽

A. Hosni Abdalaty ◽

A. Salcedo ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Prospective Cohort ◽

Biochemical Failure ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Hormone Therapy and Radiotherapy for Intermediate Risk Prostate Cancer

Seminars in Radiation Oncology ◽

10.1016/j.semradonc.2007.09.002 ◽

2008 ◽

Vol 18 (1) ◽

pp. 7-14 ◽

Author(s):

Irwin Lee ◽

Howard Sandler

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Patterns of Daily Practice of Hormone Therapy in Unfavorable and Favorable Intermediate-Risk Prostate Cancer: Results of the French PROACT Survey

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.1113 ◽

2017 ◽

Vol 99 (2) ◽

pp. E213

Author(s):

Y. Belkacemi ◽

I. Latorzef ◽

A. Hasbini ◽

D. Pasquier ◽

A. Toledano ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Daily Practice ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text

Refining Intermediate Risk Prostate Cancer: An Analysis of Prostate Biopsy Pathology and Implications for Hormone Therapy With Dose Escalated Radiation

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.1028 ◽

2012 ◽

Vol 84 (3) ◽

pp. S390

Author(s):

M.C. Ranck ◽

S. Liauw

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Prostate Biopsy ◽

Intermediate Risk ◽

Risk Prostate Cancer

Download Full-text